OncLive.com @OncLive · 26 Aug 2026
🚨BREAKING: The news the pancreatic cancer field has been awaiting is here. The @FDA has approved daraxonrasib for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least 1 prior systemic therapy or are not candidates for multi-agent https://t.co/6cZxdYAAuY
2 918Views
19Likes
6Reposts
1Replies
2Quotes
0Bookmarks
Is that a lot?
24.3×vs this author's median120 views is typical
80Percentile for this authorof 5 recent posts
1.01×vs 10K–100K median2 896 views is typical
5.80%Reachviews ÷ followers
0.96%Engagement rateof viewers reacted